Promed P.Lach R.Glowacki sp. j. Company Profile - Poland | Financials & Key Executives

Promed P.Lach R.Glowacki sp. j. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: All Other Nondepository Credit Intermediation | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities | All Other Support Services | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals | Other Justice, Public Order, and Safety Activities

Full name: Promed P.Lach R.Glowacki sp. j.

Profile Updated: February 14, 2024

Promed P.Lach R.Glowacki sp. j is a company specializing in gastrology solutions and services. It operates in the [industry and segments of operation] industry.

Headquarters
Ul. Olszanska 5G
Krakow; Malopolskie; Postal Code: 31-513

Contact Details: Purchase the Promed P.Lach R.Glowacki sp. j. report to view the information.

Website: http://www.cmpromed.pl

Basic Information

Total Employees:

Purchase the Promed P.Lach R.Glowacki sp. j. report to view the information.

Outstanding Shares:

Purchase the Promed P.Lach R.Glowacki sp. j. report to view the information.

Incorporation Date:

January 21, 2003

Key Executives

Purchase this report to view the information.

Associate

Purchase this report to view the information.

Associate

Ownership Details

Purchase this report to view the information.

Company Performance

Financial values in the chart are available after Promed P.Lach R.Glowacki sp. j. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

19.78%▲

Total operating revenue

25.97%▲

Operating profit (EBIT)

24.16%▲

EBITDA

25.01%▲

Net Profit (Loss) for the Period

20.05%▲

Total assets

20.81%▲

Total equity

24.41%▲

Operating Profit Margin (ROS)

0.13%▲

Net Profit Margin

0.01%▲

Return on Equity (ROE)

-1.51%▼

Debt to Equity Ratio

0.22%▲

Quick Ratio

0.07%▲

Cash Ratio

0.23%▲

Similar companies

Related EMIS Industry Reports